Home » CardioFocus Launches Trial for HeartLight Device
CardioFocus Launches Trial for HeartLight Device
CardioFocus is launching a clinical trial for its HeartLight direct-visualization ablation device for treating atrial fibrillation.
The device enables electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility.
The first HeartLight version won pre-market approval from the FDA in April 2016.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May